Browsing by Sponsor/Funder Gilead Sciences Inc
Showing results 1 to 5 of 5
| Issue Date | Title | Author(s) |
|---|---|---|
| 1-Aug-2016 | Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study | Lemoine, MN; Shimakawa, Y; Njie, R; Taal, M; Ndow, G, et al |
| 6-Nov-2020 | HIV antivirals affect endothelial activation and endothelial-platelet crosstalk. | Khawaja, AA; Taylor, KA; Lovell, AO; Nelson, M; Gazzard, B, et al |
| 1-Dec-2016 | Natural history of chronic HBV infection in West Africa: a longitudinal population-based study from The Gambia | Shimakawa, Y; Lemoine, M; Njai, HF; Bottomley, C; Ndow, G, et al |
| Apr-2019 | Pharmacological impact of antiretroviral therapy on platelet function to investigate HIV-associated cardiovascular risk | Taylor, KA; Smyth, E; Rauzi, F; Cerrone, M; Khawaja, AA, et al |
| 1-Sep-2022 | Prevalence and clinical significance of occult hepatitis B infection in The Gambia, West Africa. | Ndow, G; Cessay, A; Cohen, D; Shimakawa, Y; Gore, ML, et al |